Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

WellPoint Offers Simvastatin Free Trial; Preferred Brand Lipitor Left In Dust?

Executive Summary

WellPoint beneficiaries will be able to receive up to four months of generic simvastatin as an incentive to switch from a branded cholesterol-lowering agent

You may also be interested in...



Generic Statins Make Sense In Lower CV Risk Patients, WellPoint Asserts

Generic statins can provide equal cardiovascular benefits - particularly in patients with low to moderate risk of cardiovascular events - while offering substantial cost savings over brand-name drugs, according to a study recently released by WellPoint

Generic Statins Make Sense In Lower CV Risk Patients, WellPoint Asserts

Generic statins can provide equal cardiovascular benefits - particularly in patients with low to moderate risk of cardiovascular events - while offering substantial cost savings over brand-name drugs, according to a study recently released by WellPoint

Merck Pushes Discount Zocor; Health Plans Are Wary, But Pfizer Is Concerned

The mixed response to Merck's efforts to reach rebate agreements with health plans to place brand Zocor on the lowest cost-sharing tiers of their formularies suggests it is unlikely such a strategy would be broadly adopted by brand firms going forward

Latest News
See All
UsernamePublicRestriction

Register

PS048185

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel